Literature DB >> 17215649

Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis.

Jeanie Park1, Vito Campese.   

Abstract

Resistant hypertension is defined as failure to achieve goal blood pressure despite adherence to 3 different antihypertensive medications, one of which must be a diuretic. True resistant hypertension must be distinguished by apparent resistant hypertension, of which an important cause is medication nonadherence, which can be recognized through a variety of monitoring strategies and may be improved through better patient education. A thorough history and examination should focus on evaluating for associated factors such as medication and illicit drug use, alcoholism, obesity, and obstructive sleep apnea. Further evaluation to differentiate apparent resistant hypertension from true resistant hypertension should include consideration of ambulatory blood pressure monitoring to rule out white coat hypertension. Routine laboratory work will reveal chronic kidney disease, which is the most common associated factor in resistant hypertension. Secondary or identifiable causes of resistant hypertension include primary aldosteronism, renovascular disease, and pheochromocytoma. Diagnostic evaluation for identifiable causes should be tailored for each patient and guided by signs and symptoms, as well as risks and benefits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215649      PMCID: PMC8110090          DOI: 10.1111/j.1524-6175.2007.6106.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  36 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

Review 3.  Clinical practice. Resistant or difficult-to-control hypertension.

Authors:  Marvin Moser; John F Setaro
Journal:  N Engl J Med       Date:  2006-07-27       Impact factor: 91.245

4.  Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study.

Authors:  J Redon; C Campos; M L Narciso; J L Rodicio; J M Pascual; L M Ruilope
Journal:  Hypertension       Date:  1998-02       Impact factor: 10.190

Review 5.  Resistant hypertension: diagnosis and management.

Authors:  Dimitris P Papadopoulos; Vasilios Papademetriou
Journal:  J Cardiovasc Pharmacol Ther       Date:  2006-06       Impact factor: 2.457

6.  Pharmaceutical care program for patients with uncontrolled hypertension. Report of a double-blind clinical trial with ambulatory blood pressure monitoring.

Authors:  Mauro Silveira de Castro; Flávio Danni Fuchs; Melissa Costa Santos; Paulo Maximiliano; Miguel Gus; Leila Beltrami Moreira; Maria Beatriz Cardoso Ferreira
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

7.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

Review 8.  Antihypertensive treatment based on home or office blood pressure--the THOP trial.

Authors:  Elly Den Hond; Jan A Staessen; Hilde Celis; Robert Fagard; Louis Keary; Guy Vandenhoven; Eoin T O'Brien
Journal:  Blood Press Monit       Date:  2004-12       Impact factor: 1.444

9.  Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.

Authors:  B C van Jaarsveld; P Krijnen; F H Derkx; J Deinum; A J Woittiez; C T Postma; M A Schalekamp
Journal:  J Hum Hypertens       Date:  2001-10       Impact factor: 3.012

Review 10.  How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials.

Authors:  Knut Schroeder; Tom Fahey; Shah Ebrahim
Journal:  Arch Intern Med       Date:  2004-04-12
View more
  9 in total

1.  Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system.

Authors:  John J Sim; Simran K Bhandari; Jiaxiao Shi; In Lu A Liu; David A Calhoun; Elizabeth A McGlynn; Kamyar Kalantar-Zadeh; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2013-10       Impact factor: 7.616

Review 2.  Resistant hypertension.

Authors:  Sheldon W Tobe; Richard Lewanczuk
Journal:  Can J Cardiol       Date:  2009-05       Impact factor: 5.223

3.  Resistant hypertension workup and approach to treatment.

Authors:  Anastasios Makris; Maria Seferou; Dimitris P Papadopoulos
Journal:  Int J Hypertens       Date:  2010-12-26       Impact factor: 2.420

4.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

5.  Clinical approach in treatment of resistant hypertension.

Authors:  Jennifer Frank; David Sommerfeld
Journal:  Integr Blood Press Control       Date:  2009-07-30

Review 6.  Resistant hypertension and chronotherapy.

Authors:  Ingrid Prkacin; Diana Balenovic; Vesna Djermanovic-Dobrota; Iva Lukac; Petra Drazic; Iva-Klara Pranjic
Journal:  Mater Sociomed       Date:  2015-04-05

7.  Intensive monitoring of adherence to treatment helps to identify "true" resistant hypertension.

Authors:  Walnéia Aparecida de Souza; Maricene Sabha; Fabrício de Faveri Favero; Gun Bergsten-Mendes; Juan Carlos Yugar-Toledo; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-04       Impact factor: 3.738

Review 8.  Arterial stiffness as a cause of resistant hypertension?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-05       Impact factor: 3.738

9.  Acute Sildenafil Use Reduces 24-Hour Blood Pressure Levels in Patients With Resistant Hypertension: A Placebo-Controlled, Crossover Trial.

Authors:  Arthur Santa Catharina; Rodrigo Modolo; Alessandra Mileni Versuti Ritter; Thiago Quinaglia; Rivadávio Fernandes Batista de Amorim; Heitor Moreno; Ana Paula de Faria
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.